Hrt Financial LP Aytu Biopharma, Inc Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.15 - $4.0 $2,339 - $62,384	15,596 New	15,596 $2,000
Q4 2021 Feb 14, 2022	SELL	$1.35 - $2.95 $36,836 - $80,493	-27,286 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.78 - $5.12 $81,598 - $150,282	-29,352 Reduced 51.82%	27,286 $78,000
Q2 2021 Aug 16, 2021	BUY	$4.73 - $7.56 $267,897 - $428,183	56,638 New	56,638 $283,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $88.7M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.